Abstract PS3-05: Evaluation of the safety and efficacy of ivonescimab in combination with chemotherapy as first-line (1L) treatment for triple-negative breast cancer (TNBC)
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Xiaojia Wang, Quchang Ouyang, Can Tian, Xiying Shao, Jian Huang, Zhanhong Chen, Yongsheng Wang, Tao Sun, Tienan Yi, Xufang Yu, Zhongmin Wang, Baiyong Li, Michelle Xia
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4411286442